FYS*101*18 Description

First-Year Seminar

Advances in modern medicine have led to more effective drugs and treatments, but the costs associated with these improvements can be prohibitive. As a result governments, insurance companies and pharmaceutical companies need to make choices about which diseases to target and when to ration healthcare. These economically based decisions have dramatic ethical consequences that separate the rich from the poor and first world countries from developing countries. Through readings, documentaries, writing assignments and class discussions, students will investigate the money pipeline from consumers and the government to universities, pharmaceutical companies and insurance companies and grapple with bioethical questions relating to the economic considerations of human life and which diseases are most important to cure. The process of designing, producing and marketing a drug, as well as the effectiveness and sustainability of healthcare models around the world will be discussed.